---header---
Glucophage Xr 500mg Film-coated Tablets
Glucophage (metformin) is an oral diabetes medicine that helps control blood sugar levels. Glucophage is used together with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus. (Please consult your physician before taking any medication)
---product---
-
How to use
Take Glucophage XR with a meal, unless your doctor tells you
-
Ingredients
Glucophage xr 500 mg tablets contain the inactive ingredients hypromellose, microcrystalline cellulose, sodium carboxymethyl cellulose, and magnesium stearate.
-
Hazards and Cautions
There have been postmarketing cases of metformin-associated lactic acidosis, including fatal cases. these cases had a subtle onset and were accompanied by nonspecific symptoms such as malaise, myalgias, abdominal pain, respiratory distress, or increased somnolence; however, hypotension and resistant bradyarrhythmias have occurred with severe acidosis. metforminassociated lactic acidosis was characterized by elevated blood lactate concentrations (>5 mmol/l), anion gap acidosis (without evidence of ketonuria or ketonemia), and an increased lactate: pyruvate ratio; metformin plasma levels were generally >5 mcg/ml. metformin decreases liver uptake of lactate increasing lactate blood levels which may increase the risk of lactic acidosis, especially in patients at risk.if metformin-associated lactic acidosis is suspected, general supportive measures should be instituted promptly in a hospital setting, along with immediate discontinuation of glucophage xr. in glucophage xr treated patients with a diagnosis or strong suspicion of lactic acidosis, prompt hemodialysis is recommended to correct the acidosis and remove accumulated metformin (metformin hydrochloride is dialyzable with a clearance of up to 170 ml/min under good hemodynamic conditions). hemodialysis has often resulted in reversal of symptoms and recovery.educate patients and their families about the symptoms of lactic acidosis and, if these symptoms occur, instruct them to discontinue glucophage xr and report these symptoms to their healthcare provider.insulin and insulin secretagogues (e.g., sulfonylurea) are known to cause hypoglycemia. glucophage xr may increase the risk of hypoglycemia when combined with insulin and/or an insulin secretagogue. therefore, a lower dose of insulin or insulin secretagogue may be required to minimize the risk of hypoglycemia when used in combination with glucophage xr.inform patients that hypoglycemia may occur when glucophage xr is coadministered with oral sulfonylureas and insulin. explain to patients receiving concomitant therapy the risks of hypoglycemia, its symptoms and treatment, and conditions that predispose to its development.inform females that treatment with glucophage xr may result in ovulation in some premenopausal anovulatory women which may lead to unintended pregnancy.
---footer---
style
footer-vat
style
footer-language
Shop by
About Boots
- About Us
- Delivery Information
- Terms and Conditions of Sale
- Terms and Conditions
- Privacy Policy
- Returns & Refunds
Help
Get email offers and the latest news from Boots Kuwait
Enter your email address
Get Connected
Available on
Customer Service
{{gcsTimings}}
style
footer-info
Copyright © Boots International Management Services Limited. All rights reserved. me.boots.com is a trading name of Boots International Management Services Limited. Registered office: Nottingham NG2 3AA.Registered in England. Company number7136280.
style
footer-copyright, footer-v3